Investigating the in vivo potential of genetically engineered lymphocytes on hematological malignancies using patient derived xenograft models. Godkjenningsdato 14.03.2025 Godkjent fra 31.03.2025 Godkjent til 01.03.2029 ALURES NTS Database ID: NTS-NO-922393